Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes

CompletedOBSERVATIONAL

Enrollment

6,180

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

January 30, 2025

Study Completion Date

February 11, 2025

Conditions

STEMIAcute Myocardial Infarction

Trial Locations (1)

Krannert Cardiovascular Research Center, Indianapolis

All Listed Sponsors

lead

Rohan Dharmakumar

OTHER

NCT06851325 - Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes | Biotech Hunter | Biotech Hunter